6990 — Sichuan Kelun-Biotech Biopharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$108.71bn
- HK$103.19bn
- CNY2.06bn
Brief: Accelerated Bookbuild Offering Of H Shares In Sichuan Kelun-Biotech Biopharmaceutical, Term Sheet Shows
Brief: Sichuan Kelun-Biotech Biopharmaceutical New Indication Application For Sac-Tmt Accepted By NMPA
Brief: Sichuan Kelun-Biotech Biopharmaceutical Acquired Large- Denomination Negotiable Certificate Of Deposit
Brief: Kelun-Biotech's Novel ADC Drug SKB518 Has Been Granted The Clearance Of IND From The United States Food And Drug Administration (FDA)
Brief: Sichuan Kelun-Biotech Biopharmaceutical Syas New Drug Clearance For Adc Drug Skb518
Brief: Sichuan Kelun-Biotech Biopharmaceutical Gets Investigational New Drug Approval By NMPA
Brief: Sichuan Kelun-Biotech Biopharmaceutical Posts FY Loss Attributable RMB266.8 Million
Brief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes For Structured Deposits
Brief: Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (Sac-TMT) Approved For Marketing In Second Indication By NMPA For EGFRm NSCLC
Brief: Sichuan Kelun-Biotech Says Cetuximab N01 Injection Approved For Marketing By NMPA China
Brief: Sichuan Kelun-Biotech Biopharmaceutical To Subscribe For Structured Deposit From CITIC Bank
Brief: Sichuan Kelun-Biotech Biopharmaceutical Gets Drug Approval For SKB445 By NMPA China
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says ANTI-PD-L1 Tagitanlimab Approved For Marketing By NMPA
Brief: HBM Holdings Announces License Agreement With Windward Bio AG
Brief: Windward Bio Launches With $200 Million Series A Financing
Brief: Sichuan Kelun-Biotech Biopharmaceutical New Drug Application For Core Product Trastuzumab Botidotin Accepted
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says Anti-Pd-L1 Tagitanlimab Approved For Marketing By Nmpa Of China
Brief: Sichuan Kelun-Biotech Biopharmaceutical To Subscribe 2 Structured Deposits From Industrial Bank
Brief: Sichuan Kelun-Biotech Biopharma Announces Investigational New Drug Approval For SKB501 By NMPA China